Nuvalent CDO sells 5,500 shares in planned trade
Nuvalent, Inc. Chief Development Officer Darlene Noci reported an exercise-and-sell transaction in Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nuvalent, Inc. Chief Development Officer Darlene Noci reported an exercise-and-sell transaction in Class A Common Stock. She exercised stock options to acquire 5,500 shares at $27.85 per share and sold 5,500 shares in open-market trades at a weighted average price of $123.51 per share.
The filing shows these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2024. After the sale, she directly held 58,117 shares of Nuvalent Class A Common Stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,500 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 5,500 | $27.85 | $153K |
| Sale | Class A Common Stock | 5,500 | $123.51 | $679K |
Footnotes (3)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.47 to $123.56, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
- F3. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
Class A Common Stock financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Nuvalent (NUVL) Chief Development Officer Darlene Noci report in this Form 4?
Were the Nuvalent (NUVL) insider transactions made under a Rule 10b5-1 plan?
What stock option terms are disclosed in the Nuvalent (NUVL) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.